期刊簡介預計審稿時間：

JCO PO is a peer-reviewed, online-only, article-based journal publishing original research, reports, opinions, and reviews that advance the science and practice of precision oncology and define genomics- and other biomarker-driven clinical care of patients with cancer. Innovative and timely scientific and educational content provide a deeper understanding of actionable cancer genomics, personalized translational and clinical oncology research, and recent treatment advances based on tumor molecular profiling. The scope of publications includes all types of clinical research (basket trials, exceptional response results, informatics, computational approaches, mechanism and evidence-based case reports and small series of educational value), and extensive expert driven commentary, editorials and reviews considering the challenges and value of targeted therapies based on genomic analyses. JCO PO is published by the American Society of Clinical Oncology (ASCO).

JCO PO 是一本同行評審的在線文章型期刊，發表原創研究、報告、觀點和評論，推動精準腫瘤學的科學和實踐，并定義癌癥患者的基因組學和其他生物標志物驅動的臨床護理。創新且及時的科學和教育內容提供了對可操作的癌癥基因組學、個性化轉化和臨床腫瘤學研究以及基于腫瘤分子分析的最新治療進展的更深入了解。出版物范圍包括所有類型的臨床研究（籃子試驗、特殊反應結果、信息學、計算方法、機制和循證病例報告以及具有教育價值的小系列），以及大量專家驅動的評論、社論和評論，考慮到基于基因組分析的靶向治療的挑戰和價值。 JCO PO 由美國臨床腫瘤學會 (ASCO) 出版。

《Jco Precision Oncology》(Jco精準腫瘤學)編輯部通訊方式為TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, USA, PA, 19103。如果您需要協助投稿或潤稿服務，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務十年，熟悉發表政策，可為您提供一對一投稿指導，避免您在投稿時頻繁碰壁，節省您的寶貴時間，有效提升發表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內容。